Spatially Resolved Epithelial–Immune Heterogeneity Identifies an Endometriosis Subtype with Molecular Features of Endometriosis-Associated Ovarian Cancer
Using spatial transcriptomics, this study identifies a distinct "cancer-like" endometriosis subtype characterized by oncogenic signaling and an immunosuppressive microenvironment, providing a molecular framework for understanding its progression to endometriosis-associated ovarian cancer.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
For decades, doctors have understood that endometriosis, a painful condition where tissue similar to the uterine lining grows outside the uterus, is more than just a source of chronic pain. In a small but significant number of women, this benign tissue can transform into specific types of ovarian cancer. The medical community has long searched for the invisible bridge between the two: a moment where a harmless lesion begins to behave like a dangerous one. The challenge has been that these early changes often look identical to normal tissue under a standard microscope, hiding their true nature until it is too late. To solve this, researchers have begun using a new kind of map-making technology that does not just look at cells, but listens to the thousands of chemical messages they are sending while they are still in their exact location within the tissue. This approach allows scientists to see how different cell types, such as immune defenders and the tissue itself, are interacting in real time, revealing hidden patterns that signal a shift from health to disease.
A team of scientists at the Gemelli University Hospital in Rome recently applied this technology to a group of fourteen women with various stages of ovarian endometriosis and related cancers. Their goal was to compare the biological landscapes of simple, benign endometriosis against a specific, rare subtype that displays a "cancer-like" molecular signature, even though it looks normal under a microscope. By analyzing the genetic activity of individual cells within these tissue samples, the researchers discovered that this specific subtype, which they call "cancer-like endometriosis," is biologically distinct. Despite appearing ordinary, the cells in these lesions are already running a complex set of instructions typically associated with cancer development. They are actively remodeling their surroundings, repairing damage, and sending out signals that recruit immune cells in a way that creates a protective shield, effectively hiding the tissue from the body's natural defenses.
The study revealed that these "cancer-like" lesions are not just passive growths; they are active environments where the tissue and the immune system have formed a strange, cooperative relationship. In healthy tissue or simple endometriosis, the immune system usually patrols the area with a balanced mix of different soldier cells. However, in these specific lesions, the researchers found a distinct imbalance. The tissue is heavily infiltrated by neutrophils, a type of white blood cell that usually fights infection, but here they seem to be stuck in a cycle of damage and repair. These cells accumulate just beneath the surface of the tissue lining, creating a zone of constant inflammation. At the same time, the number of cytotoxic T-cells, which are the body's primary killers of abnormal cells, drops significantly. This combination creates a quiet, immunosuppressed zone where the tissue can grow and change without being attacked, mimicking the conditions that allow a tumor to establish itself.
What makes this discovery particularly striking is the specific molecular profile of the tissue lining these lesions. The researchers found that the cells in these "cancer-like" areas express high levels of a protein called MUC5B, which is usually involved in protecting and repairing mucous membranes. This protein acts as a marker for a specific type of cell that is trying to heal itself, but in this context, the healing process has gone on for too long. The tissue also shows signs of being stuck in a "secretory" state, a phase normally seen in the uterus only during a specific window when it is preparing to receive an embryo. In these lesions, this state persists indefinitely, creating a microenvironment that tolerates the presence of the tissue rather than rejecting it. This suggests that the body's own mechanisms for protecting a pregnancy are being hijacked by the endometriosis, allowing it to survive and potentially evolve into cancer.
The researchers traced the path of how these lesions might evolve into the two main types of ovarian cancer linked to endometriosis: clear cell carcinoma and endometrioid carcinoma. They found that the "cancer-like" lesions share a strong molecular resemblance with clear cell carcinoma, suggesting they may be on a direct path toward becoming that specific type of cancer. In contrast, another type of lesion known as "atypical endometriosis," which has been traditionally viewed as the main precursor to cancer, showed a different genetic signature that aligned more closely with endometrioid carcinoma. This indicates that there may be two distinct roads leading to ovarian cancer from endometriosis, driven by different biological mechanisms. One road is paved by a chronic, inflammatory repair process that creates a secretory, immune-tolerant niche, while the other is driven by hormonal signals that push cells to divide rapidly.
By mapping these differences, the study provides a new way to think about risk. It suggests that not all endometriosis is the same, and that a specific subset of lesions, identifiable by their unique immune environment and genetic activity, carries a higher risk of turning malignant. The presence of specific immune cells, such as the neutrophils and the altered macrophages found in these lesions, could serve as early warning signs. The researchers propose that in the future, doctors might be able to look for these specific molecular fingerprints to identify which patients need closer monitoring. While the study is based on a relatively small group of patients and requires further validation, it offers a clear, spatial view of how a benign condition can quietly reprogram its surroundings to pave the way for cancer, offering a new target for understanding and potentially preventing this dangerous transformation.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.